KIA
ETON icon

Kraematon Investment Advisors’s Eton Pharmaceutcials ETON Stock Holding History

Kraematon Investment Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,300
Closed -$6.49K – 122
2022
Q4 		$6.49K Buy
+2,300
New +$6.18K 0.01% 216

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Kraematon Investment Advisors's ETON Position: Q1 2023 in Review

Kraematon Investment Advisors sold out of Eton Pharmaceutcials (ETON) in Q1 2023, closing a stake of 2,300 shares — an estimated $6.49K sold.

Kraematon Investment Advisors first reported a position in ETON in Q4 2022 and held it in 1 quarter. The position peaked at $6.49K in Q4 2022. 35 funds tracked by Wall St. Rank hold ETON as of Q1 2023.

  • Kraematon Investment Advisors reported no remaining Eton Pharmaceutcials position as of Q1 2023 after selling out during the quarter.
  • Kraematon Investment Advisors sold 2,300 Eton Pharmaceutcials shares in Q1 2023, an estimated $6.49K.
  • Kraematon Investment Advisors first reported a position in Eton Pharmaceutcials in Q4 2022 and held it in 1 quarter.
  • Kraematon Investment Advisors's Eton Pharmaceutcials position peaked at $6.49K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2023.

Based on Kraematon Investment Advisors's 13F filing for Q1 2023, filed 13 Apr 2023.